UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000010943
Receipt No. R000012808
Scientific Title Analysis of the association of serum cytokeratin-7 with hepato-pancreato-biliary malignancies
Date of disclosure of the study information 2013/06/12
Last modified on 2021/04/23 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Analysis of the association of serum cytokeratin-7 with hepato-pancreato-biliary malignancies
Acronym serum cytokeratin-7 and hepato-pancreato-biliary malignancies
Scientific Title Analysis of the association of serum cytokeratin-7 with hepato-pancreato-biliary malignancies
Scientific Title:Acronym serum cytokeratin-7 and hepato-pancreato-biliary malignancies
Region
Japan

Condition
Condition hepato-pancreato-biliary malignancies
Classification by specialty
Hepato-biliary-pancreatic medicine
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Analize the association of serum cytokeratin-7 with hepato-pancreato-biliary malignancies
Basic objectives2 Bio-availability
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes over all survival
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria patients with hepato-pancreato-biliary malignancies
Key exclusion criteria none
Target sample size 300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Ikeda Fusao
Organization Okayama university graduate school of medicine dentistry and pharmaceutical science
Division name ganstoenterology and hepatology
Zip code
Address 2-5-1 shikata-cho okayama
TEL 086-235-7219
Email

Public contact
Name of contact person
1st name
Middle name
Last name Ikeda Fusao
Organization Okayama university graduate school of medicine dentistry and pharmaceutical science
Division name ganstoenterology and hepatology
Zip code
Address 2-5-1 shikata-cho okayama
TEL
Homepage URL
Email

Sponsor
Institute department of ganstoenterology and hepatology
Okayama university graduate school of medicine dentistry and pharmaceutical science
Institute
Department

Funding Source
Organization Okayama university graduate school of medicine dentistry and pharmaceutical science
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 06 Month 12 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 03 Month 26 Day
Date of IRB
2013 Year 03 Month 26 Day
Anticipated trial start date
2013 Year 03 Month 26 Day
Last follow-up date
2016 Year 12 Month 31 Day
Date of closure to data entry
2025 Year 12 Month 31 Day
Date trial data considered complete
Date analysis concluded
2020 Year 12 Month 31 Day

Other
Other related information prospective study

Management information
Registered date
2013 Year 06 Month 12 Day
Last modified on
2021 Year 04 Month 23 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012808